Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis

NCT02864082 is registered in ClinicalTrials.gov with Patagonia Pharmaceuticals, LLC as lead sponsor.

NCT NCT02864082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02864082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Bilateral Comparison, Vehicle-Controlled, Safety and Tolerability Study of Topical PAT-001 for the Treatment of Congenital Ichthyosis
Lead sponsor
Patagonia Pharmaceuticals, LLC
Phase
Phase 2
Overall status
Completed
Start date
March 8, 2017
Completion date
December 4, 2018
Enrollment
19 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

congenital ichthyosis